Cizzle Biotechnology strengthens North American rollout of CIZ1B lung cancer test (LON:CIZ) 2 October 2025
Drax Group Expands Energy Flexibility with Strategic Battery Acquisition, says Longspur Research 4 November 2025
Manx Financial Group New Overdraft Tech Partnership with Fiinu Plc Targets UK Liquidity Crunch (Video)
Roquefort Therapeutics secures exclusivity with Coiled Therapeutics RTO, eyeing AIM relist and NASDAQ (Video)
Quadrise Strengthens Position in Central America with Panama Trial Success – VSA Capital 24 September 2025
Lords Group Trading Share Price Tipped to Double on Positive 1H25 Results, Cavendish 19 September 2025
Windar Photonics builds momentum on H1 progress, platform enhanced for growth – Zeus Capital 16 September 2025
Wizz Air Holdings PLC (WIZZ.L) Stock Analysis: Evaluating a 36% Potential Upside Amid Market Challenges 7 November 2025
W.A.G Payment Solutions (WPS.L): Analyst Consensus and Growth Potential with a 10.20% Upside 7 November 2025
ZIGUP PLC ORD 50P (ZIG.L) Stock Analysis: A 37% Upside Potential in the Industrials Sector 7 November 2025
Volution Group PLC (FAN.L) Stock Analysis: Assessing a 12.26% Potential Upside for Investors 7 November 2025
Cizzle Biotechnology strengthens North American rollout of CIZ1B lung cancer test (LON:CIZ) 2 October 2025
Drax Group Expands Energy Flexibility with Strategic Battery Acquisition, says Longspur Research 4 November 2025
Manx Financial Group New Overdraft Tech Partnership with Fiinu Plc Targets UK Liquidity Crunch (Video)
Roquefort Therapeutics secures exclusivity with Coiled Therapeutics RTO, eyeing AIM relist and NASDAQ (Video)
Quadrise Strengthens Position in Central America with Panama Trial Success – VSA Capital 24 September 2025
Lords Group Trading Share Price Tipped to Double on Positive 1H25 Results, Cavendish 19 September 2025
Windar Photonics builds momentum on H1 progress, platform enhanced for growth – Zeus Capital 16 September 2025
Wizz Air Holdings PLC (WIZZ.L) Stock Analysis: Evaluating a 36% Potential Upside Amid Market Challenges 7 November 2025
W.A.G Payment Solutions (WPS.L): Analyst Consensus and Growth Potential with a 10.20% Upside 7 November 2025
ZIGUP PLC ORD 50P (ZIG.L) Stock Analysis: A 37% Upside Potential in the Industrials Sector 7 November 2025
Volution Group PLC (FAN.L) Stock Analysis: Assessing a 12.26% Potential Upside for Investors 7 November 2025
Liquidia Corporation (LQDA) Stock Analysis: A 118.59% Potential Upside Opportunity in Biotech 17 June 2025
Dyne Therapeutics, Inc. (DYN) Stock Analysis: Exploring a 218% Potential Upside in the Biotech Sector 17 June 2025
10x Genomics, Inc. (TXG) Stock Report: Exploring Potential Upside Amid Healthcare Sector Dynamics 17 June 2025
Artivion, Inc. (AORT) Stock Analysis: A 12.54% Upside Potential Amidst Healthcare Innovations 17 June 2025
GRAIL, Inc. (GRAL) Stock Analysis: Navigating Challenges with a 19% Revenue Growth in Healthcare Innovation 17 June 2025
Warby Parker Inc. (WRBY) Stock Analysis: Navigating Growth with 11.9% Revenue Surge and Strategic Buy Ratings 17 June 2025
Vera Therapeutics, Inc. (VERA) Stock Analysis: Biotech Innovator with 189.96% Upside Potential 17 June 2025
AdaptHealth Corp. (AHCO) Stock Analysis: Robust Analyst Ratings and Nearly 50% Potential Upside 17 June 2025
UFP Technologies, Inc. (UFPT) Stock Analysis: Riding a 41% Revenue Growth Wave with a 30% Upside Potential 17 June 2025
Neogen Corporation (NEOG) Stock Analysis: Uncovering a 59% Potential Upside Amid Healthcare Challenges 17 June 2025
GeneDx Holdings Corp. (WGS) Stock Analysis: Harnessing 39.6% Revenue Growth with a 42% Upside Potential 17 June 2025
Azenta, Inc. (AZTA) Stock Analysis: Exploring a 35.55% Potential Upside with a Strong Hold Consensus 17 June 2025
Twist Bioscience Corporation (TWST): Analyst Consensus and Growth Potential Highlight a Promising Investment Opportunity 17 June 2025
Janux Therapeutics, Inc. (JANX) Stock Analysis: Biotechnology Pioneer with 256.30% Potential Upside 17 June 2025
Crinetics Pharmaceuticals, Inc. (CRNX) Stock Analysis: A Biotech Powerhouse with a 132.91% Potential Upside 17 June 2025
LivaNova PLC (LIVN) Stock Analysis: Unveiling a 35.82% Upside Potential in the Medical Devices Market 17 June 2025
Viking Therapeutics, Inc. (VKTX): Analyst Ratings Highlight a Potential 234% Upside for Investors 17 June 2025
ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: Exploring a Potential 108% Upside in the Biotech Sector 17 June 2025
Firering Strategic Minerals Kiln Upgrades, Hydration Circuit and Untapped Margin Potential (Video) 23 September 2025
Acuity RM Group CEO David Rajakovich Unveils AI-Driven Turnaround and New Growth Strategy (Video) 19 September 2025
Manx Financial Group New Overdraft Tech Partnership with Fiinu Plc Targets UK Liquidity Crunch (Video) 18 September 2025
Roquefort Therapeutics secures exclusivity with Coiled Therapeutics RTO, eyeing AIM relist and NASDAQ (Video) 11 September 2025
Aston Martin reports lower Q3 volumes but expects stronger Q4 driven by Valhalla deliveries 29 October 2025
Cizzle Biotechnology strengthens North American rollout of CIZ1B lung cancer test (LON:CIZ) 2 October 2025
Quadrise Strengthens Position in Central America with Panama Trial Success – VSA Capital 24 September 2025
Lords Group Trading Share Price Tipped to Double on Positive 1H25 Results, Cavendish 19 September 2025
Windar Photonics builds momentum on H1 progress, platform enhanced for growth – Zeus Capital 16 September 2025
Drax Group Expands Energy Flexibility with Strategic Battery Acquisition, says Longspur Research 4 November 2025
Wizz Air Holdings PLC (WIZZ.L) Stock Analysis: Evaluating a 36% Potential Upside Amid Market Challenges 7 November 2025
W.A.G Payment Solutions (WPS.L): Analyst Consensus and Growth Potential with a 10.20% Upside 7 November 2025
ZIGUP PLC ORD 50P (ZIG.L) Stock Analysis: A 37% Upside Potential in the Industrials Sector 7 November 2025
Volution Group PLC (FAN.L) Stock Analysis: Assessing a 12.26% Potential Upside for Investors 7 November 2025
